Star Imaging SME: Check IPO Date, Live Subscription and Key Details
Star Imaging & Path Lab Ltd. is a healthcare service provider that offers comprehensive diagnostic imaging services and clinical laboratory tests, including both routine and specialized tests. The company's services span across various medical fields such as Radiology (X-ray, CT Scan, Mammography, 4D ultrasound, Bone Mineral Density), Pathology (Haematology, Microbiology, PCR, Histopathology, Immunology & Bio Chemistry), and Cardio-diagnostics. The company operates on a mixed business model, serving B2G (Public-private partnership model), B2C (direct consumers), and B2B (private hospitals) segments. In Fiscal 2024, B2G contributed 58.46% of the revenue, B2C 34.67%, and B2B 6.87%.
Price Range
₹135.00-142.00
Issue Size
62.65
Lot Size
1,000 shares
IPO Type
BSE SME
GMP
-
Est. Listing Price
₹142
Invisible
-
Invisible
-
Key Metrics
Check Live GMP
Face Value
₹10
EPS
9.16
P/E Ratio
15.5
RoNW
40.65%
ROE
40.65%
Debt to Equity
0.69
Timeline
IPO Opens
8 Aug
IPO Closes
12 Aug
Allotment
13 Aug
Listing
18 Aug
IPO Timeline & Listing Details
| Event | Date | Details |
|---|---|---|
| IPO Open Date | 8 August 2025 | Subscription starts |
| IPO Close Date | 12 August 2025 | Subscription ends |
| Allotment Date | 13 August 2025 | Allotment |
| Listing Date | 18 August 2025 | Listing |
Investment Categories
| Category | Lots | Amount |
|---|---|---|
Individual | 2 | ₹2,84,000 |
SHNI (Min) | 3 | ₹4,26,000 |
SHNI (Max) | 7 | ₹9,94,000 |
BHNIAbove ₹10,00,000 | 8 | ₹11,36,000 |
IPO Objectives
- To Meet Working Capital Requirement.
- Repayment/prepayment of certain borrowings availed of by the Company.
- Funding the Capital Expenditure towards purchase of Refurbished Medical Equipment in running facilities.
- General corporate purposes.
Strengths
- The company offers a comprehensive range of diagnostic services, including radiology and pathology, positioning it as a one-stop-shop for medical tests with specialized expertise.
- Its diverse business model serves government agencies, businesses, and individuals, with the stable government segment providing a consistent revenue stream.
- The company has shown strong financial growth, with revenue increasing by 5% and profit after tax rising by 28% between FY24 and FY25.
- The money from the IPO will be used for working capital and to buy refurbished medical equipment to enhance its facilities and improve operational efficiency.
- The company ensures accuracy and reliability of results through its proper sample collection and processing procedures.
Weaknesses
- There is a high reliance on the government segment for revenue, which can make the company vulnerable to government budget cuts or payment delays.
- The business requires a lot of working capital, and a significant portion of the IPO funds is needed to meet these ongoing financial needs.
- The company faces intense competition from both national and regional players in the diagnostics market, which can put pressure on its prices.
- With the company's P/E ratio not available, it's difficult for investors to accurately value it and compare it with competitors.
- The company's use of refurbished medical equipment may lead to higher long-term maintenance costs and could limit its technological capabilities in a fast-changing industry.
Financial Performance
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets (₹ Cr.) | 98.16 | 81.64 | 61.23 |
| Revenue (₹ Cr.) | 83.79 | 79.97 | 58.68 |
| PAT (₹ Cr.) | 15.96 | 12.45 | 0.58 |
| Net Worth (₹ Cr.) | 47.15 | 31.35 | 18.93 |
Peer Comparison
| Company | P/B Ratio | P/E Ratio | RONW (%) | Net Worth (₹ Cr.) |
|---|
Subscription Details
Daily Bids Status
| Category | Day 1 | Day 2 | Day 3 |
|---|---|---|---|
| QIB | 0x | 0x | 12.85x |
| NII | 0.13x | 0.39x | 4.38x |
| S-HNI | 0.09x | 0.43x | 2.89x |
| B-HNI | 0.15x | 0.36x | 5.12x |
| RII | 0.05x | 0.41x | 2.3x |
| EMP | 0x | 0.1x | 0.31x |
| Total | 0.05x | 0.28x | 5.66x |
Overall Subscription Statistics
| Category | Shares Offered | Shares Bid | Bid Amount (₹ Cr) |
|---|---|---|---|
| QIB | 8,71,000 | 1,11,88,000 | 158.87 |
| NII | 6,57,000 | 28,75,000 | 40.83 |
| Small NII | 2,19,000 | 6,33,000 | 8.99 |
| Big NII | 4,38,000 | 22,42,000 | 31.84 |
| RII | 15,28,000 | 35,16,000 | 49.93 |
| EMP | 52,000 | 16,000 | 0.23 |
| Total | 31,08,000 | 1,75,95,000 | 249.85 |
Company Details
- Star Imaging & Path Lab Ltd.
- 4B/4, Tilak Nagar, Near Sant Pura, Tilak Nagar West Delhi, New Delhi-110018
- +91 9990019189
- cs@starimaging.in
- https://www.starimaging.in/
Registrar Details
- Kfin Technologies Limited
- 04067162222, 04079611000
- sipll.ipo@kfintech.com
- https://kosmic.kfintech.com/ipostatus/